These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21334859)

  • 21. Efficacy and safety of pregabalin in the treatment of alcohol and benzodiazepine dependence.
    Oulis P; Konstantakopoulos G
    Expert Opin Investig Drugs; 2012 Jul; 21(7):1019-29. PubMed ID: 22568872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pregabalin on subjective sleep disturbance symptoms during withdrawal from long-term benzodiazepine use.
    Rubio G; Bobes J; Cervera G; Terán A; Pérez M; López-Gómez V; Rejas J
    Eur Addict Res; 2011; 17(5):262-70. PubMed ID: 21701173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The benzodiazepine withdrawal syndrome.
    Pétursson H
    Addiction; 1994 Nov; 89(11):1455-9. PubMed ID: 7841856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzodiazepine dependence and its treatment with low dose flumazenil.
    Hood SD; Norman A; Hince DA; Melichar JK; Hulse GK
    Br J Clin Pharmacol; 2014 Feb; 77(2):285-94. PubMed ID: 23126253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Off-Label Use of Medications for Treatment of Benzodiazepine Use Disorder.
    Sabioni P; Bertram J; Le Foll B
    Curr Pharm Des; 2015; 21(23):3306-10. PubMed ID: 26088120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive effects of pregabalin in the treatment of long-term benzodiazepine-use and dependence.
    Oulis P; Kalogerakou S; Anyfandi E; Konstantakopoulos G; Papakosta VM; Masdrakis V; Tsaltas E
    Hum Psychopharmacol; 2014 May; 29(3):224-9. PubMed ID: 24532157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregabalin: a review of its use in adults with generalized anxiety disorder.
    Frampton JE
    CNS Drugs; 2014 Sep; 28(9):835-54. PubMed ID: 25149863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability.
    Montgomery S; Emir B; Haswell H; Prieto R
    Curr Med Res Opin; 2013 Oct; 29(10):1223-30. PubMed ID: 23808960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of pregabalin on sleep in generalized anxiety disorder.
    Holsboer-Trachsler E; Prieto R
    Int J Neuropsychopharmacol; 2013 May; 16(4):925-36. PubMed ID: 23009881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Pregabalin (Lyrica(®) ) help patients reduce their use of benzodiazepines? A comparison with gabapentin using the Norwegian Prescription Database.
    Bramness JG; Sandvik P; Engeland A; Skurtveit S
    Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):883-6. PubMed ID: 22545971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of pregabalin in patients with hypnotic-dependent insomnia.
    Cho YW; Song ML
    J Clin Sleep Med; 2014 May; 10(5):545-50. PubMed ID: 24812540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care.
    Vicens C; Bejarano F; Sempere E; Mateu C; Fiol F; Socias I; Aragonès E; Palop V; Beltran JL; Piñol JL; Lera G; Folch S; Mengual M; Basora J; Esteva M; Llobera J; Roca M; Gili M; Leiva A
    Br J Psychiatry; 2014 Jun; 204(6):471-9. PubMed ID: 24526745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzodiazepines revisited--will we ever learn?
    Lader M
    Addiction; 2011 Dec; 106(12):2086-109. PubMed ID: 21714826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk versus risk: a review of benzodiazepine reduction in older adults.
    Paquin AM; Zimmerman K; Rudolph JL
    Expert Opin Drug Saf; 2014 Jul; 13(7):919-34. PubMed ID: 24905348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benzodiazepine harm: how can it be reduced?
    Lader M
    Br J Clin Pharmacol; 2014 Feb; 77(2):295-301. PubMed ID: 22882333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzodiazepine withdrawal seizures and management.
    Hu X
    J Okla State Med Assoc; 2011 Feb; 104(2):62-5. PubMed ID: 21815323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of pregabalin in generalised anxiety disorder: A critical review of the literature.
    Baldwin DS; den Boer JA; Lyndon G; Emir B; Schweizer E; Haswell H
    J Psychopharmacol; 2015 Oct; 29(10):1047-60. PubMed ID: 26259772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome.
    Rickels K; Schweizer E; Garcia España F; Case G; DeMartinis N; Greenblatt D
    Psychopharmacology (Berl); 1999 Jan; 141(1):1-5. PubMed ID: 9952057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
    Klein E; Colin V; Stolk J; Lenox RH
    Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review.
    Freynhagen R; Backonja M; Schug S; Lyndon G; Parsons B; Watt S; Behar R
    CNS Drugs; 2016 Dec; 30(12):1191-1200. PubMed ID: 27848217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.